PRESS RELEASES:

Ambler, PA – July 30, 2019 – MBF Therapeutics (MBFT), the leader in the development of DNA-based immunotherapeutic checkpoint inhibitor vaccines for the animal health market, announces that it has signed an exclusive option agreement with the University of North Carolina to evaluate UNC’s checkpoint inhibitor traps and calcium phosphate nanoparticle delivery system to evaluate in combination with MBFT’s proprietary immunomodulating technologies to create advanced immunotherapeutic treatments for cancer and infectious diseases in animal health.

June 5, 2019

PHILADELPHIA (June 5, 2019) — Tom Tillett, founder and CEO of Ambler, Pa.-based MBF
Therapeutics (MBFT), will speak at the ASPIRE Middle-Market Dealmakers Conference in
Philadelphia on Wednesday, June 12.

May 9, 2019

San Antonio, Texas – Southwest Research Institute (SwRI) has licensed its patented calcium phosphate nanoparticle delivery system exclusively to MBF Therapeutics (MBFT) to develop advanced immunotherapeutic treatments for canine melanoma.


SwRI holds two U.S. patents for its calcium phosphate nanoparticle (CaPNP) drug delivery system.


The non-toxic, biocompatible drug delivery vehicle safely dissolves under specific conditions. MBFT will conduct clinical trials of an advanced immunotherapeutic vaccine to prevent and treat cancer in “man’s best friend” and eventually other companion animals and livestock.

November 2, 2017

The collaboration will further advance a canine melanoma vaccine and other vaccines for

cancer and infectious diseases in animals

October 30, 2017

MBF Therapeutics, Inc. a clinical stage animal health company developing checkpoint inhibitor vaccines for cancer and infectious diseases, today announced that Thomas Tillett, Chief Executive Officer, will present at the PACT Capital Conference in Philadelphia, PA on Thursday, November 2, 2017 at 9:45am EDT.

November 17, 2016

PHILADELPHIA — Companion animals, like their human counterparts, are living longer, healthier lives. Yet one out of every four dogs is diagnosed with cancer. Melanoma, the deadliest form of skin cancer, affects humans and dogs through exposure to UV light, yet dogs are often left with few treatment options beyond surgery and traditional chemotherapy.

Please reload

NEWS ARTICLES:

August 6, 2019

The government may be covering up the severity of the crisis.  African swine fever, a highly contagious virus, has spread to every province in China. The country is the world’s biggest pork producer, and home to half the pigs on the planet.

July 31, 2019

The agreement, which covers animal health applications of the technology, will allow MBF Therapeutics of Ambler to evaluate UNC’s checkpoint inhibitor traps and calcium phosphate nanoparticle delivery system in combination with the company's proprietary immunomodulating technologies to create immunotherapeutic treatments for cancer and infectious diseases in animal health.

May 3, 2019

US start-up Man's Best Friend Therapeutics (MBFT) aims to conduct a clinical study of its treatment for canine melanoma in late 2019 or early 2020, upon completion and USDA review of its pilot work in dogs.

June 25, 2018

In an era of cancer immunotherapy, vaccines are getting fresh consideration as a therapeutic approach.  Frustrated for years by lackluster results, cancer vaccine research is now advancing more briskly, revitalized by the success of a handful of new medicines that unleash the immune system on tumors.  Estimates vary, but one count puts the number of cancer vaccine candidates in clinical testing across the industry at over 300!

Genes and cancer: Hot trend in veterinary product development

October 13, 2018

While the 2018 Investment Forum hosted recently by the Kansas City Animal Health Corridor was not specifically designed to focus on cancer in animals, many of the products presented did just that, and most of them had a genetic component to their technology. The forum, which allows...

With Rise in Chemotherapy for Pets, Higher Risks for Veterinary Staff

October 18, 2018

During a 2006 biopsy of a worrisome growth on his thyroid gland, while a needle was still lodged in his neck, Arizona veterinarian Brett Cordes was surprised by a question from his endocrinologist.

The Nobel Prize in Physiology or Medicine 2018

October 1, 2018

The Nobel Assembly at Karolinska Institutet has today decided to award the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo

May 16, 2018

PIDC, Philadelphia's public-private economic development corporation and partner with the City of Philadelphia in the StartupPHL initiative, has partnered with Ben Franklin for StartupPHL Seed Fund II, to invest in seed and early-stage technology-focused enterprises located in the City of Philadelphia.  

November 29, 2017

US start-up gains exclusive licence for checkpoint inhibitor tech.  Man's Best Friend Therapeutics (MBFT) has furthered its partnership with the Wistar Institute to develop immunotherapeutic vaccines for companion animals.

November 2, 2017

A suburban Philadelphia animal health company has entered into an exclusive license agreement with the Wistar Institute to further advance a canine melanoma vaccine and other vaccines for cancer and infectious diseases in animals.

October 19, 2017

Vaccines show promise for arresting equine melanoma

Please reload

  • LinkedIn Classic
  • Facebook Classic
  • Twitter Social Icon

​Follow us at @mbftherapeutics

© 2013 MBF Therapeutics